Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
lisinopril	O
/	O
Levofloxacin	O
/	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
chest	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
cardiac	O
catheterization	O
with	O
bare	O
metal	O
stents	O
to	O
the	O
Right	O
coronary	O
artery	O
and	O
left	O
circumflex	O
artery.	O
History	O
of	O
Present	O
Illness:	O
___	O
woman	O
w/	O
a	O
PMHx	O
of	O
CAD	O
(noted	O
on	O
cath	O
___,	O
Afib	O
on	O
dabigatran,	O
and	O
valvular	O
HD	O
presented	O
to	O
___	O
with	O
2	O
days	O
of	O
intermittent	O
midline	O
chest	O
discomfort	O
as	O
well	O
as	O
bilateral	O
jaw	O
discomfort,	O
increasing	O
weakness,	O
and	O
nausea	O
w/	O
no	O
vomiting.	O
She	O
has	O
been	O
taking	O
nitroglycerin	O
with	O
intermittent	O
relief	O
of	O
this	O
pain	O
but	O
has	O
resisted	O
until	O
today	O
coming	O
to	O
the	O
hospital	O
until	O
her	O
daughter	O
urged	O
her.	O
In	O
the	O
___,	O
EKG	O
was	O
notable	O
for	O
A-Fib	O
@87bpm	O
and	O
ST	O
elev	O
in	O
3,	O
aVF,	O
V5-V6.	O
Troponin	O
was	O
elevated	O
to	O
1.65.	O
Heparin	O
and	O
clopidogrel	O
were	O
held	O
in	O
setting	O
of	O
dabigatran	O
and	O
hx	O
of	O
UGI	B-Upper_gastrointestinal_haemorrhage
bleeds.	B-Upper_gastrointestinal_haemorrhage
Pt	O
was	O
transferred	O
to	O
___	O
for	O
cath.Initial	O
___	O
vitals:	O
99.2	O
F	O
P:96.	O
RR:	O
26	O
BP:113/80.	O
O2	O
sat:	O
100%.	O
In	O
cath	O
lab,	O
pt	O
was	O
found	O
to	O
have	O
blockage	O
of	O
OM	O
and	O
RCA.	O
OM	O
was	O
stented	O
but	O
pt's	O
symptoms	O
failed	O
to	O
improve.	O
Pt	O
subsequently	O
received	O
RCA	O
with	O
resolution	O
of	O
symptoms.	O
Case	O
was	O
otherwise	O
uncomplicated	O
and	O
pt	O
is	O
asymptomatic	O
on	O
transfer	O
to	O
CCU.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS:	O
(-)Diabetes,	O
(+)Dyslipidemia,(+)Hypertension	O
2.	O
CARDIAC	O
HISTORY:	O
Cath	O
___	O
vessel	O
by	O
cardiac	O
catheter	O
___	O
with	O
60%	O
LAD	O
stenosis,	O
75%	O
left	O
circumflex/obtuse	O
marginal	O
stenosis	O
and	O
60-70%	O
proximal	O
RCA	O
stenosis	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
Mitral	O
regurgitation	O
Paroxysmal	O
atrial	O
fibrillation	O
Sinus	O
bradycardia	O
Hypertension	O
Hyperlipidemia	O
Coronary	O
artery	O
disease	O
Gastroesophageal	O
reflux	O
Hiatal	O
hernia	O
Anemia	O
Morbid	O
obesity	O
Venous	O
insufficiency	O
Degenerative	O
disc	O
disease	O
CHF	O
diastolyic	O
Social	O
History:	O
___	O
Family	O
History:	O
Daughter	O
has	O
a	O
hx	O
of	O
CAD	O
and	O
is	O
s/p	O
2	O
stents.	O
Physical	O
Exam:	O
VS:	O
T=98.4	O
BP=115/68	O
HR=94	O
RR=20	O
O2	O
sat=96%	O
on	O
RA	O
GENERAL:	O
laying	O
comfortably	O
in	O
bed,	O
NAD.	O
Oriented	B-Delirium
x3.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthalesma.	O
NECK:	O
No	O
JVD	O
appreciated	O
but	O
unable	O
to	O
raise	O
pt	O
to	O
45	O
degrees	O
CARDIAC:	O
PMI	O
located	O
in	O
___	O
intercostal	O
space,	O
midclavicular	O
line.	O
Irregulary	O
irregular.	O
No	O
m/r/g.	O
No	O
thrills,	O
lifts.	O
No	O
S3	O
or	O
S4.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB,	O
no	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM	O
or	O
tenderness.	O
Abd	O
aorta	O
not	O
enlarged	O
by	O
palpation.	O
No	O
abdominial	O
bruits.	O
EXTREMITIES:	O
B/l	O
2+	O
pitting	O
leg	O
edema.	O
No	O
femoral	O
bruits.	O
SKIN:	O
Cath	O
site	O
with	O
dressing	O
in	O
place	O
L	O
tigh	O
(c/d/i).	O
No	O
stasis	O
dermatitis,	O
ulcers,	O
scars,	O
or	O
xanthomas.	O
PULSES:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Pertinent	O
Results:	O
Admission/	O
Relevant	O
Labs:	O
___	O
06:00PM	O
BLOOD	O
WBC-8.9	O
RBC-3.63*	O
Hgb-9.5*	O
Hct-30.2*	O
MCV-83	O
MCH-26.2*	O
MCHC-31.5	O
RDW-16.8*	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
___	O
PTT-41.0*	O
___	O
___	O
06:00PM	O
BLOOD	O
Glucose-118*	O
UreaN-22*	O
Creat-0.8	O
Na-140	O
K-3.4	O
Cl-104	O
HCO3-24	O
AnGap-15	O
___	O
06:00PM	O
BLOOD	O
AST-50*	O
CK(CPK)-356*	O
___	O
06:00PM	O
BLOOD	O
CK-MB-25*	O
MB	O
Indx-7.0*	O
cTropnT-0.57*	O
___	O
04:14AM	O
BLOOD	O
CK-MB-38*	O
MB	O
Indx-6.1*	O
___	O
07:10AM	O
BLOOD	O
Calcium-9.1	O
Phos-3.0	O
Mg-1.6	O
___	O
07:10AM	O
BLOOD	O
%HbA1c-5.9	O
eAG-123	O
.	O
Discharged	O
Labs:	O
___	O
07:10AM	O
BLOOD	O
WBC-7.6	O
RBC-3.69*	O
Hgb-9.7*	O
Hct-31.4*	O
MCV-85	O
MCH-26.4*	O
MCHC-31.1	O
RDW-16.6*	O
Plt	O
___	O
___	O
07:10AM	O
BLOOD	O
___	O
PTT-30.5	O
___	O
___	O
07:10AM	O
BLOOD	O
Glucose-119*	O
UreaN-21*	O
Creat-0.8	O
Na-140	O
K-4.5	O
Cl-105	O
HCO3-26	O
AnGap-14	O
.	O
Cath:	O
___	O
1.	O
Selective	O
coronary	O
angiography	O
in	O
this	O
right	O
dominant	O
system	O
demonstrated	O
3	O
vessel	O
coronary	O
artery	O
disease.	O
The	O
LMCA	O
was	O
free	O
of	O
angiographically	O
apparant	O
coronary	O
artery	O
disease.	O
The	O
LAD	O
had	O
a	O
60%	O
lesion	O
in	O
its	O
mid	O
segment,	O
and	O
an	O
80%	O
lesion	O
in	O
the	O
D1.	O
The	O
LCx	O
had	O
a	O
hazy	O
95%	O
lesion	O
at	O
a	O
bifurcation	O
of	O
the	O
OM1	O
with	O
extension	O
back	O
into	O
the	O
proximal	O
LCx.	O
The	O
proximal	O
RCA	O
had	O
a	O
diffuse,	O
80-90%	O
lesion	O
with	O
a	O
aneurysmal	O
vs.	O
ulcerated	O
segment.	O
The	O
mid	O
RCA	O
had	O
a	O
50%	O
lesion.	O
2.	O
Limited	O
resting	O
hemodynamics	O
revealed	O
normal	O
systemic	O
arterial	O
blood	O
pressure	O
with	O
a	O
central	O
aortic	O
blood	O
pressure	O
of	O
132/73	O
mmHg.	O
The	O
LVEDP	O
was	O
moderately	O
elevated	O
at	O
23	O
mmHg	O
consistent	O
with	O
moderate	O
diastolic	O
heart	O
failure.	O
There	O
was	O
no	O
gradient	O
across	O
the	O
aortic	O
valve	O
with	O
pullback.	O
3.	O
Successful	O
PCI	O
of	O
LCX	O
bifurcation	O
disease	O
with	O
Integrity	O
RX	O
2.5	O
x	O
18	O
mm	O
BMS	O
to	O
lower	O
pole	O
of	O
OM	O
branch	O
back	O
into	O
main	O
LCX	O
vessel.	O
Upper	O
pole	O
of	O
OM	O
branch	O
was	O
pre-dilated.	O
Excellent	O
result.	O
4.	O
Ongoing	O
discomfort	O
during	O
procedure,	O
so	O
decided	O
to	O
proceed	O
to	O
intervention	O
on	O
proximal	O
RCA	O
lesion.	O
Successful	O
PCI	O
with	O
Integrity	O
RX	O
3.0	O
x	O
26	O
mm	O
bare	O
metal	O
stent	O
with	O
excellent	O
result.	O
5.	O
Successful	O
hemostasis	O
at	O
right	O
femoral	O
arterial	O
access	O
site	O
using	O
___	O
Fr	O
Exoseal	O
vascular	O
closure	O
device.	O
FINAL	O
DIAGNOSIS:	O
1.	O
Three	O
vessel	O
coronary	O
artery	O
disease.	O
2.	O
Normal	O
systemic	O
arterial	O
blood	O
pressure.	O
3.	O
Moderately	O
elevated	O
LVEDP	O
consistent	O
with	O
moderate	O
diastolic	O
heart	O
failure.	O
4.	O
Inferolateral	O
STEMI	O
with	O
successful	O
PCI	O
using	O
BMI	O
of	O
LCX/OM	O
and	O
proximal	O
RCA.	O
5.	O
Aspirin	O
81	O
mgs	O
daily	O
indefinitely,	O
Clopidogrel	O
75	O
mgs	O
for	O
minimum	O
6	O
weeks.	O
.	O
TTE:	O
___	O
The	O
left	O
atrium	O
is	O
markedly	O
dilated.	O
No	O
left	O
atrial	O
mass/thrombus	O
seen	O
(best	O
excluded	O
by	O
transesophageal	O
echocardiography).	O
The	O
right	O
atrium	O
is	O
markedly	O
dilated.	O
Left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
severe	O
hypokinesis	O
of	O
the	O
inferolateral	O
wall.	O
The	O
remaining	O
segments	O
contract	O
normally	O
(LVEF	O
=	O
50-55	O
%).	O
[Intrinsic	O
left	O
ventricular	O
systolic	O
function	O
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
valvular	O
regurgitation.]	O
The	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
with	O
normal	O
free	O
wall	O
contractility.	O
[Intrinsic	O
right	O
ventricular	O
systolic	O
function	O
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
tricuspid	O
regurgitation.]	O
The	O
ascending	O
aorta	O
and	O
aortic	O
arch	O
are	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
Trace	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
An	O
eccentric,	O
anteriorly	O
directed	O
jet	O
of	O
moderate	O
to	O
severe	O
(3+)	O
mitral	O
regurgitation	O
is	O
seen.	O
Moderate	O
to	O
severe	O
[3+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
The	O
end-diastolic	O
pulmonic	O
regurgitation	O
velocity	O
is	O
increased	O
suggesting	O
pulmonary	O
artery	O
diastolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
regional	O
systolic	O
dysfunction	O
c/w	O
CAD.	O
Moderate	O
to	O
severe	O
mitral	O
regurgitation.	O
Pulmonary	O
artery	O
hypertension.	O
Moderate	O
to	O
severe	O
tricuspid	O
regurgitation.	O
Dilated	O
thoracic	O
aorta.	O
Brief	O
Hospital	O
Course:	O
___	O
female	O
w/	O
a	O
hx	O
of	O
CAD,	O
Afib,	O
valvular	O
heart	O
disease	O
(MR+TR)	O
who	O
presented	O
to	O
___	O
complaining	O
of	O
CP	O
radiating	O
to	O
jaw	O
for	O
3	O
days.	O
On	O
work	O
up	O
found	O
to	O
have	O
ST	O
elevation	O
inferiorlateral	O
MI	O
transfered	O
urgently	O
to	O
cath	O
lab	O
at	O
___.	O
.	O
#STEMI:	O
EKG	O
at	O
___	O
notable	O
for	O
ST	O
elevations	O
in	O
AvF,	O
III,	O
and	O
v5,	O
v6	O
and	O
had	O
(+)trop	O
which	O
was	O
concerning	O
for	O
LCx	O
teritory	O
STEMI.	O
She	O
was	O
transferred	O
to	O
___	O
for	O
urgent	O
cath.	O
In	O
the	O
cath	O
lab,	O
patient	O
was	O
found	O
to	O
have	O
blockage	O
of	O
OM	O
and	O
RCA.	O
Patient	O
had	O
successful	O
PCI	O
of	O
LCX	O
bifurcation	O
disease	O
with	O
Integrity	O
RX	O
2.5	O
x	O
18	O
mm	O
BMS	O
to	O
lower	O
pole	O
of	O
OM	O
branch	O
back	O
into	O
main	O
LCX	O
vessel.	O
Subsequently	O
patient	O
continued	O
to	O
have	O
ongoing	O
discomfort	O
during	O
procedure,	O
so	O
decision	O
was	O
___	O
to	O
proceed	O
to	O
intervention	O
on	O
proximal	O
RCA	O
lesion	O
with	O
successful	O
PCI	O
with	O
Integrity	O
RX	O
3.0	O
x	O
26	O
mm	O
bare	O
metal	O
stent	O
with	O
excellent	O
result.	O
Patient	O
was	O
transfered	O
to	O
CCU	O
for	O
monitoring	O
where	O
she	O
remained	O
free	O
of	O
chest	O
pain.	O
She	O
was	O
continued	O
of	O
aspirin	O
and	O
started	O
on	O
clobidogrel,	O
atorvastain,	O
valsartan.	O
Her	O
home	O
metorprolol	O
dose	O
was	O
also	O
increased.	O
She	O
had	O
TTE	O
once	O
day	O
after	O
cath	O
which	O
showed	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
severe	O
hypokinesis	O
of	O
the	O
inferolateral	O
wall	O
with	O
EF	O
50-55%.	O
She	O
was	O
seen	O
by	O
physical	O
theraphy	O
on	O
the	O
day	O
of	O
discahrged	O
and	O
deemed	O
safe	O
to	O
go	O
home	O
with	O
services.	O
She	O
will	O
follow	O
up	O
with	O
cardiologist	O
Dr.	O
___	O
further	O
___	O
of	O
her	O
CAD.	O
.	O
#AFIB:	O
Stable;	O
She	O
was	O
rate	O
controlled	O
with	O
metoprolol	O
and	O
discahrged	O
on	O
Metoporlol	O
XL	O
50mg	O
daily.	O
She	O
was	O
continued	O
on	O
Pradaxa.	O
.	O
#	O
Acute	O
on	O
Chornic	O
Diastolic	O
CHF:	O
Patient's	O
contined	O
to	O
be	O
euvolemic.	O
ON	O
day	O
of	O
discharge	O
she	O
had	O
swelling	O
of	O
her	O
foot	O
therefore	O
she	O
was	O
restarted	O
on	O
her	O
home	O
lasix	O
dose.	O
She	O
continued	O
to	O
have	O
good	O
oxygen	O
saturation	O
and	O
stable	O
from	O
respiratory	O
stanpoint.	O
.	O
#	O
Hypertension:	O
Her	O
Blood	O
pressure	O
was	O
well	O
controlled	O
on	O
metoprolol.	O
Valsartan	O
was	O
added	O
on	O
day	O
of	O
discharge	O
but	O
BP	O
dec	O
to	O
90/50	O
so	O
was	O
not	O
prescribed	O
on	O
discharge.	O
.	O
#	O
Hyperlidiemia:	O
She	O
was	O
started	O
on	O
atorvatatin.	O
.	O
#Anemia:	O
Most	O
likely	O
secondary	O
to	O
chronic	O
GI	O
bleed	O
___	O
to	O
peptic	O
ulcer.	O
Her	O
hematocrit	O
reamined	O
stable.	O
She	O
will	O
follow	O
up	O
with	O
her	O
PCP	O
for	O
further	O
___.	O
.	O
#GERD:	O
Stable,	O
continued	O
omeprazole	O
CODE:	O
Full	O
.	O
Transitions	O
of	O
Care:	O
-	O
Patient	O
will	O
have	O
her	O
Chem-7	O
and	O
hct	O
checked	O
on	O
___	O
___	O
results	O
faxed	O
to	O
Dr.	O
___.	O
-	O
She	O
will	O
follow	O
up	O
with	O
Dr.	O
___	O
management	O
of	O
her	O
anemia	O
and	O
CAD.	O
-	O
She	O
will	O
follow	O
up	O
with	O
Dr.	O
___	O
managment	O
of	O
CAD.	O
Medications	O
on	O
Admission:	O
Preadmission	O
medications	O
listed	O
are	O
correct	O
and	O
complete.	O
Information	O
was	O
obtained	O
from	O
PatientFamily/Caregiver.	O
1.	O
Furosemide	O
40	O
mg	O
PO	O
BID	O
2.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
3.	O
Dabigatran	O
Etexilate	O
150	O
mg	O
PO	O
BID	O
4.	O
Metoprolol	O
Tartrate	O
12.5	O
mg	O
PO	O
BID	O
5.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
6.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
PRN	O
Chest	O
Pain	O
7.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Dabigatran	O
Etexilate	O
150	O
mg	O
PO	O
BID	O
3.	O
Furosemide	O
40	O
mg	O
PO	O
BID	O
4.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
RX	O
*atorvastatin	O
80	O
mg	O
one	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
6.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
do	O
not	O
stop	O
taking	O
this	O
medicine	O
unless	O
Dr.	O
___	O
you	O
to	O
RX	O
*clopidogrel	O
75	O
mg	O
one	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
7.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
Hold	O
SBP	O
<	O
90,	O
HR<	O
55	O
RX	O
*metoprolol	O
succinate	O
50	O
mg	O
one	O
tab	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
8.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
PRN	O
Chest	O
Pain	O
RX	O
*nitroglycerin	O
0.4	O
mg	O
one	O
tab	O
sublingually	O
every	O
5	O
minutes	O
for	O
total	O
of	O
2	O
doses	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
9.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
10.	O
Outpatient	O
Lab	O
Work	O
Please	O
check	O
Chem-7	O
abd	O
hct	O
on	O
___	O
___	O
results	O
to	O
Dr.	O
___	O
at	O
Phone:	O
___	O
Fax:	O
___	O
ICD-9:	O
585.2	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Inferolateral	O
ST	O
elevation	O
myocardial	O
infarction	O
Hypertension	O
Atrial	O
fibrillation	O
Diastolic	O
Congestive	O
heart	O
failure	O
Anemia	O
GERD	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
You	O
had	O
a	O
heart	O
attack	O
and	O
had	O
a	O
cardiac	O
catheterization.	O
The	O
catheterization	O
showed	O
2	O
blockages	O
and	O
you	O
received	O
2	O
bare	O
metal	O
stents	O
to	O
keep	O
the	O
arteries	O
open.	O
It	O
is	O
extremely	O
important	O
that	O
you	O
take	O
a	O
baby	O
aspirin	O
and	O
clopidogrel	O
(Plavix)	O
every	O
day	O
to	O
prevent	O
the	O
stents	O
from	O
clotting	O
off	O
and	O
causing	O
another	O
heart	O
attack.	O
Do	O
not	O
stop	O
taking	O
plavix	O
or	O
miss	O
any	O
doses	O
unless	O
Dr.	O
___	O
you	O
it	O
is	O
OK	O
to	O
do	O
so.	O
An	O
echocardiogram	O
showed	O
that	O
your	O
heart	O
is	O
still	O
strong	O
despite	O
and	O
area	O
that	O
was	O
affected	O
by	O
the	O
heart	O
attack.	O
You	O
will	O
need	O
to	O
see	O
Dr.	O
___	O
Dr	O
___	O
again	O
in	O
the	O
next	O
few	O
weeks	O
to	O
make	O
sure	O
you	O
are	O
tolerating	O
your	O
medicines	O
and	O
your	O
heart	O
continues	O
to	O
be	O
strong.	O
Please	O
weight	O
yourself	O
every	O
day	O
in	O
the	O
morning	O
before	O
breakfast	O
and	O
___	O
weight	O
increases	O
more	O
than	O
3	O
pounds	O
in	O
1	O
day	O
or	O
5	O
pounds	O
in	O
3	O
days.	O
Please	O
watch	O
your	O
legs	O
for	O
signs	O
of	O
more	O
swelling	O
and	O
___	O
Dr.	O
___	O
this	O
is	O
worsening.	O
Followup	O
Instructions:	O
___	O

